Last reviewed · How we verify
Ropivacaine 0.2% for L-ESPB — Competitive Intelligence Brief
marketed
Local anesthetic (amide)
Voltage-gated sodium channels
Anesthesia
Small molecule
Live · refreshed every 30 min
Target snapshot
Ropivacaine 0.2% for L-ESPB (Ropivacaine 0.2% for L-ESPB) — Poznan University of Medical Sciences. Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce regional anesthesia.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Ropivacaine 0.2% for L-ESPB TARGET | Ropivacaine 0.2% for L-ESPB | Poznan University of Medical Sciences | marketed | Local anesthetic (amide) | Voltage-gated sodium channels | |
| Lidocaine solution ("A") | Lidocaine solution ("A") | Hospital Universitari de Bellvitge | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Lidocaine gel 2% | Lidocaine gel 2% | Atlantic Health System | marketed | Local anesthetic | Voltage-gated sodium channels | |
| lamotrigine (generic Teva) | lamotrigine (generic Teva) | University of Maryland, Baltimore | marketed | Anticonvulsant / Mood stabilizer | Voltage-gated sodium channels; glutamate release inhibition | |
| Lidocaine (drug) | Lidocaine (drug) | Daniel A Tonetti, MD | marketed | Local anesthetic | Voltage-gated sodium channels | |
| Bupivacaine Liposomes(BL) | Bupivacaine Liposomes(BL) | Huazhong University of Science and Technology | marketed | Local anesthetic (liposomal formulation) | Voltage-gated sodium channels | |
| lidocaine infusion | lidocaine infusion | Medical University of Warsaw | marketed | Local anesthetic / Sodium channel blocker | Voltage-gated sodium channels |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic (amide) class)
- Poznan University of Medical Sciences · 4 drugs in this class
- Nantes University Hospital · 3 drugs in this class
- Bozyaka Training and Research Hospital · 2 drugs in this class
- ASST Gaetano Pini-CTO · 2 drugs in this class
- Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
- Chiang Mai University · 1 drug in this class
- Beijing Tiantan Hospital · 1 drug in this class
- Complejo Hospitalario Universitario de Granada · 1 drug in this class
- Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
- China Medical University, China · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Ropivacaine 0.2% for L-ESPB CI watch — RSS
- Ropivacaine 0.2% for L-ESPB CI watch — Atom
- Ropivacaine 0.2% for L-ESPB CI watch — JSON
- Ropivacaine 0.2% for L-ESPB alone — RSS
- Whole Local anesthetic (amide) class — RSS
Cite this brief
Drug Landscape (2026). Ropivacaine 0.2% for L-ESPB — Competitive Intelligence Brief. https://druglandscape.com/ci/ropivacaine-0-2-for-l-espb. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab